Holen Sie sich die Stockscreener-App
115.58
7.66%
8.22
Vorhandelsmarkt:
114.71
-0.87
-0.75%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$107.36
Offen:
$108.35
24-Stunden-Volumen:
20.27M
Relative Volume:
1.88
Marktkapitalisierung:
$146.28B
Einnahmen:
$18.44B
Nettoeinkommen (Verlust:
$5.36B
KGV:
27.78
EPS:
4.16
Netto-Cashflow:
$5.41B
1W Leistung:
+15.10%
1M Leistung:
+13.31%
6M Leistung:
+57.55%
1J Leistung:
+50.72%
1-Tages-Spanne:
$108.29
$115.90
1-Wochen-Bereich:
$100.68
$115.90
52-Wochen-Spanne:
$56.32
$115.90
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Vergleichen Sie LRCX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
115.58 | 135.88B | 18.44B | 5.36B | 5.41B | 4.16 |
|
ASML
Asml Holding Nv
|
804.16 | 311.86B | 34.96B | 10.23B | 10.02B | 26.11 |
|
AMAT
Applied Materials Inc
|
170.15 | 130.19B | 28.61B | 6.83B | 5.82B | 8.39 |
|
KLAC
Kla Corp
|
959.28 | 123.07B | 12.15B | 4.06B | 3.74B | 30.39 |
|
TER
Teradyne Inc
|
115.56 | 18.74B | 2.83B | 469.17M | 568.90M | 2.89 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Lam Research Corp. stock outperforms competitors on strong trading day - MSN
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Increases Stake in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation (LRCX) Announces Change in Independent Auditor - GuruFocus
Rep. Byron Donalds Purchases Shares of Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Dynamic Technology Lab Private Ltd Acquires Shares of 14,394 Lam Research Corporation $LRCX - MarketBeat
Why Lam Research Rallied Today - The Motley Fool
Lam Research stock hits 52-week high at $108.35 - Investing.com
Woodline Partners LP Has $143.99 Million Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Kestra Investment Management LLC Has $513,000 Position in Lam Research Corporation $LRCX - MarketBeat
Ashton Thomas Private Wealth LLC Has $5.71 Million Position in Lam Research Corporation $LRCX - MarketBeat
Fred Alger Management LLC Has $6.06 Million Holdings in Lam Research Corporation $LRCX - MarketBeat
Nissay Asset Management Corp Japan ADV Grows Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation (LRCX): A Bull Case Theory - MSN
Advisors Asset Management Inc. Increases Stock Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research Deposition Tool Tackles Critical Advanced Packaging Challenges in IC Manufacturing - EE Times Asia
Teza Capital Management LLC Makes New $489,000 Investment in Lam Research Corporation $LRCX - MarketBeat
Cinctive Capital Management LP Takes Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research (NASDAQ:LRCX) Price Target Raised to $120.00 - MarketBeat
AQR Capital Management LLC Buys 352,264 Shares of Lam Research Corporation $LRCX - MarketBeat
Nippon Life Global Investors Americas Inc. Reduces Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Sold by Jacobs Levy Equity Management Inc. - MarketBeat
60-Micron Ultra-Thick Film Technology: Lam Research's New VECTOR TEOS 3D Revolutionizes AI Chip Packaging - Stock Titan
Lam Research Introduces VECTOR® TEOS 3D to Address Critical Advanced Packaging Challenges in Chipmaking - Yahoo Finance
EFG Asset Management North America Corp. Sells 8,905 Shares of Lam Research Corporation $LRCX - MarketBeat
Eventide Asset Management LLC Raises Stake in Lam Research Corporation $LRCX - MarketBeat
Can Advanced Packaging Boost Systems Sales at Lam Research in FY26? - Yahoo Finance
Why Lam Research (LRCX) is a Top Stock for the Long-Term - Yahoo Finance
Teewinot Capital Advisers L.L.C. Makes New Investment in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Stock Holdings Decreased by USS Investment Management Ltd - MarketBeat
Federation des caisses Desjardins du Quebec Boosts Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Sold by EP Wealth Advisors LLC - MarketBeat
Alliancebernstein L.P. Boosts Stake in Lam Research Corporation $LRCX - MarketBeat
Concentric Capital Strategies LP Has $3.55 Million Stake in Lam Research Corporation $LRCX - MarketBeat
Why Lam Research (LRCX) Outpaced the Stock Market Today - Yahoo Finance
Lam Research Corporation Approaches Support With Recovery in SightJuly 2025 PostEarnings & AI Based Trade Execution Alerts - beatles.ru
Here's Why Lam Research (LRCX) is a Strong Growth Stock - Yahoo Finance
Lam Research Corporation $LRCX Shares Sold by PDT Partners LLC - MarketBeat
Did Lam Research's (LRCX) Dividend Boost Offset Analyst Worries About Growth Pressures? - Yahoo Finance
Lam Research Corporation Stock (LRCX) Opinions on Morgan Stanley Downgrade - Quiver Quantitative
Voleon Capital Management LP Reduces Position in Lam Research Corporation $LRCX - MarketBeat
MAI Capital Management Has $4.99 Million Stock Position in Lam Research Corporation $LRCX - MarketBeat
UniSuper Management Pty Ltd Buys 10,400 Shares of Lam Research Corporation $LRCX - MarketBeat
NewEdge Advisors LLC Purchases 14,440 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Position Cut by Amundi - MarketBeat
Adage Capital Partners GP L.L.C. Has $102.65 Million Holdings in Lam Research Corporation $LRCX - MarketBeat
Sen. Sheldon Whitehouse Sells Lam Research Corporation (NASDAQ:LRCX) Stock - MarketBeat
Morgan Stanley Downgrades Lam Research (LRCX) to Underweight with a $92 PT - Yahoo Finance
Lam Research (LRCX) Projected to Outperform in Semiconductor Mar - GuruFocus
Alkeon Capital Management LLC Grows Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
35,749 Shares in Lam Research Corporation $LRCX Purchased by First Financial Bankshares Inc - MarketBeat
Baird Financial Group Inc. Has $37.76 Million Stake in Lam Research Corporation $LRCX - MarketBeat
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.12%
1.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):